QUANTERIX CORP (QTRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for QTRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| QTRX | Chair of the Board | 64 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| TROW | Retired Executive Vice President | 64 | ["Independent director of Price Group since 2023","Executive vice president responsible for finance, investor relations, supply chain, and information technology at Mettler-Toledo International Inc.","Chief financial officer of Mettler-Toledo (1997-2002, 2004-2014)","Division head of Mettler-Toledo’s product inspection and certain lab businesses (2002-2004)","Senior financial roles including chief financial officer at Elsag Bailey Process Automation, NV (1993-1997)","Auditor with PricewaterhouseCoopers LLP (1983-1993)","Chair of the board of directors of Quanterix Corporation","Lead independent director and member of the board of directors of Ingersoll Rand, Inc."] | ["Executive Leadership","Financial Management","Investment Management Industry","International Business Experience","Technology","Strategy Formation/Execution","Audit","Executive Compensation and Management Development"] | 2026 |
| IR | Independent Lead Director | 64 | ["Experience with publicly held industrial and life science companies","Chief financial officer","Leadership roles in strategy and operations","Experience with respect to organic growth and product innovation"] | [] | 2026 |
Biography sourced from the proxy statement filing.
On November 20, 2025, Mr. Donnelly was appointed Executive Chair of the Company and entered into an employment agreement governing his role as Executive Chair (which position also included the role and responsibilities of the Chair of the Board of Directors). As Executive Chair, Mr. Donnelly reported to the Lead Director and was responsible for providing the Company with strategic and other advice and services upon reasonable request by the Board, including, but not limited to, advice and services related to investor relations, employee relations and execution on operational and strategic initiatives. The employment agreement had an initial term ending on December 31, 2026. Under his employment agreement, Mr. Donnelly was entitled to receive a salary at the rate of $250,000 per year and an annual grant of non-qualified stock options equal to 0.15% of the shares of Company common stock outstanding on the date of grant, vesting ratably on a monthly basis for 24 months following grant. The first such grant occurred on November 20, 2025. Mr. Donnelly did not receive the second annual grant of stock options contemplated under his employment the agreement because he stepped down as Executive Chair before the first anniversary of his commencement of employment in such role.